Healthcare Business Review
About UsConferencePartner With Us
  • Patient Care
    Medical Transportation
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
  • Operations
    Consulting Service
    Digital Transformation
    Financial Services
    Healthcare Insurance
    Healthcare Marketing
    Healthcare Outsourcing
    Healthcare Staffing
    Medical Billing
  • Healthcare Services
    Facility Management Services
    Healthcare Education
    Healthcare Procurement
  • Leadership Perspectives
  • Insights
  • News
  • Magazines
  • CXO Awards
    • APAC
      • US
      • EUROPE
      • APAC
      • CANADA
      • LATAM
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

Deep Dive - Patient Support Program Management Services in Latin America

Managing Patient Support Before Continuity Breaks

By

Healthcare Business Review | Tuesday, August 18, 2026

In Latin American patient support programs, continuity rarely breaks because of a single missed call or delayed reminder. Risk builds across authorization steps, missed appointments, monitoring tests, side-effect reporting, caregiver coordination and the everyday difficulty of navigating fragmented health systems. Pharmaceutical teams funding these programs need to know more than how many patients have been contacted. They need a service model that can spot signs of disengagement early, document what is happening and give the support team time to intervene.


A patient support program can generate plenty of activity without necessarily moving the patient forward. Call logs grow, and dashboards fill up while an access barrier remains unresolved for days. What matters is whether each interaction makes the patient's next step clearer and gives the support team useful information to act on. Enrollment, consent, patient characterization, treatment initiation, medical follow-up, monitoring tests, administrative support, adverse-event reporting and program closure all need to remain connected. Good documentation allows pharmaceutical sponsors to see recurring barriers rather than receive broad summaries of activity. It should also protect patient data, maintain audit trails, standardize handoffs and support pharmacovigilance without allowing paperwork to take over the program.


Human follow-up remains central to that work. Patients with chronic, rare, orphan and oncology-related conditions may need different forms of support at different points, from education and appointment reminders to transportation guidance and caregiver involvement. Patient segmentation can guide that support, but it should not make the experience feel automated. A reminder has limited value when the real issue is fear, low health literacy, family pressure or an unanswered question about access. Trained staff need to recognize those differences and adjust the level of support while treating patients with dignity throughout the process.


Technology has a practical role to play. It should organize patient records, schedule contacts, trigger alerts, document barriers, support reporting and give sponsors a clear view of how the program is performing. But not every problem can be handed back to the patient through a digital tool. Confusion, fatigue, financial concerns or simply not having someone return a call may require human intervention. Software is most useful when it directs that attention to where it is needed. A missed laboratory test, delayed authorization, misunderstood instruction or a caregiver who was left out of the conversation can all affect whether a patient stays on therapy.


The program also has to work across the realities of Latin America. Health systems, geography, communication habits and the role of family vary from country to country. Sponsors still need standardized records and consistent processes so that performance can be measured across programs. At the same time, support has to adjust to the territory, communication channel, literacy level and individual patient profile. Too much flexibility makes consistent measurement difficult; too much standardization can overlook what a patient actually needs.


PSP Solutions SAS brings treatment continuity and program management together within this model. Its managed service structure incorporates PSP Cloud, Issabel, Power BI, Kawak and Patient University. Together, these platforms support patient enrollment, follow-up, education, barrier registration, reporting and quality control, alongside support pathways such as diagnostic assistance, infusion center visits, remote titration and administrative assistance. Pharmaceutical sponsors gain traceability and a structured way to manage the program, while patients and caregivers continue to have access to trained human support. For Latin American programs where adherence depends on both visibility into patient needs and consistent day-to-day follow-through, PSP Solutions SAS provides a practical fit.


Healthcare Business Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editorial@healthcarebusinessreview.com
  • salesus@healthcarebusinessreview.com
  • marketingus@healthcarebusinessreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Healthcare Business Review APAC. All rights reserved. Headquarteblue in Fort Lauderdale, FL, USA.

CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreviewapac.com/deep-dive/managing-patient-support-before-continuity-breaks-nwid-3429.html